{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:53:37Z","timestamp":1793235217707,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vaccine.2023.04.069","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T11:30:58Z","timestamp":1686137458000},"page":"4239-4248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cost-effectiveness of routine annual influenza vaccination by age and risk status"],"prefix":"10.1016","volume":"41","author":[{"given":"Ellen","family":"Kim DeLuca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acham","family":"Gebremariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Biggerstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-0472","authenticated-orcid":false,"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2023.04.069_b0005","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/infdis\/jiz201","article-title":"Birth Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza Infection Affects Later Influenza-Associated Illness","volume":"220","author":"Budd","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.069_b0010","unstructured":"Centers for Disease Control and Prevention. 2009 H1N1 early outbreak and disease characteristics. 2009 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/h1n1flu\/surveillanceqa.htm."},{"issue":"7","key":"10.1016\/j.vaccine.2023.04.069_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.vaccine.2023.04.069_b0020","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa1608862","article-title":"Efficacy of recombinant influenza vaccine in adults 50 years of age or older","volume":"376","author":"Dunkle","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2023.04.069_b0025","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cid\/ciy775","article-title":"Influenza vaccine effectiveness in the United States during the 2016\u20132017 season","volume":"68","author":"Flannery","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/infdis\/jiz543","article-title":"Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018\u20132019 season","volume":"221","author":"Flannery","year":"2020","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2023.04.069_b0035","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/infdis\/jiv577","article-title":"Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013\u20132014 in the United States","volume":"213","author":"Gaglani","year":"2016","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.04.069_b0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1700153","article-title":"Influenza vaccine effectiveness in the United States during the 2015\u20132016 season","volume":"377","author":"Jackson","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2023.04.069_b0045","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu647","article-title":"Influenza vaccine effectiveness in the United States during 2012\u20132013: variable protection by age and virus type","volume":"211","author":"McLean","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.069_b0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011\u20132012 season: protection against each circulating virus and the effect of prior vaccination on estimates","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2023.04.069_b0055","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of Influenza Vaccination in the United States During the 2017\u20132018 Influenza Season","volume":"69","author":"Rolfes","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"51","key":"10.1016\/j.vaccine.2023.04.069_b0060","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1016\/j.vaccine.2013.07.059","article-title":"The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly","volume":"31","author":"Van Buynder","year":"2013","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2023.04.069_b0065","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 Influenza Vaccine Effectiveness in the United States by Vaccine Type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.069_b0070","series-title":"Morbidity and Mortality Weekly Report","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","author":"Fiore","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.069_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00019053-200826020-00006","article-title":"Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness","volume":"26","author":"Prosser","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.vaccine.2023.04.069_b0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jama.2021.14131","article-title":"Influenza\u2019s Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store","volume":"326","author":"Rubin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.04.069_b0085","unstructured":"Centers for Disease Control and Prevention. People at high risk for flu complications. 2020 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/highrisk\/index.htm#:~:text=Other%20people%20at%20high%20risk,younger%20than%202%20years%20old&text=Pregnant%20women%20and%20women%20up,American%20Indians%20and%20Alaska%20Natives."},{"issue":"6","key":"10.1016\/j.vaccine.2023.04.069_b0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1750-2659.2009.00102.x","article-title":"Pediatric influenza-associated myositis - Nebraska, 2001\u20132007","volume":"3","author":"Buss","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.069_b0095","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1542\/peds.2005-2744","article-title":"Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003\u20132004","volume":"118","author":"Moore","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.069_b0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jpeds.2006.11.054","article-title":"Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors","volume":"150","author":"Newland","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2023.04.069_b0105","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2010-2011 influenza season 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2010-2011.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0110","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2011-2012 influenza season. 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2011-2012.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0115","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2012-2013 influenza season. 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2012-2013.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0120","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2013-2014 influenza season. 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2013-2014.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0125","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2014-2015 influenza season 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2014-2015.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0130","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2015-2016 influenza season 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2015-2016.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0135","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2016-2017 influenza season. 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2016-2017.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0140","unstructured":"Centers for Disease Control and Prevention. Burden estimates for the 2017-2018 influenza season. 2018 May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/2017-2018.htm."},{"issue":"10","key":"10.1016\/j.vaccine.2023.04.069_b0145","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2105\/AJPH.2012.300651","article-title":"Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009\u20132010","volume":"102","author":"Biggerstaff","year":"2012","journal-title":"Am J Public Health"},{"issue":"39","key":"10.1016\/j.vaccine.2023.04.069_b0150","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1016\/j.vaccine.2010.07.037","article-title":"Prevalence of high-risk indications for influenza vaccine varies by age, race, and income","volume":"28","author":"Zimmerman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.069_b0155","unstructured":"Centers for Disease Control and Prevention. Influenza Hospitalization Surveillance Network (FluSurv-NET). May 15, 2019]; Available from: https:\/\/www.cdc.gov\/flu\/weekly\/influenza-hospitalization-surveillance.htm."},{"issue":"8","key":"10.1016\/j.vaccine.2023.04.069_b0160","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00006454-200108000-00004","article-title":"Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience","volume":"20","author":"Neuzil","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2023.04.069_b0165","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3201\/eid1210.051015","article-title":"Health benefits, risks, and cost-effectiveness of influenza vaccination of children","volume":"12","author":"Prosser","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.069_b0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/infdis\/169.1.68","article-title":"A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease","volume":"169","author":"Edwards","year":"1994","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2023.04.069_b0180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jama.1990.03450090075029","article-title":"Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial","volume":"264","author":"Margolis","year":"1990","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.069_b0185","first-page":"127","article-title":"Evaluation of adverse events after influenza vaccination in hospital personnel","volume":"142","author":"Scheifele","year":"1990","journal-title":"CMAJ"},{"issue":"9-10","key":"10.1016\/j.vaccine.2023.04.069_b0190","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2023.04.069_b0195","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.1996.00440130090009","article-title":"Side Effects Associated With Influenza Vaccination in Healthy Working Adults: A Randomized, Placebo-Controlled Trial","volume":"156","author":"Nichol","year":"1996","journal-title":"Arch Int Med"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.069_b0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.aje.a112896","article-title":"Illness after influenza vaccination reported through a nationwide surveillance system, 1976\u20131977","volume":"111","author":"Retailliau","year":"1980","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.04.069_b0205","unstructured":"Institute of Medicine of the National Academies: Immunization Safety Review Committee, B.o.H.P.a.D.P., Immunization Safety Review: Influenza Vaccines and Neurological Complications. 2004, The National Academies Press. p. 1-76."},{"key":"10.1016\/j.vaccine.2023.04.069_b0210","unstructured":"NationalEducationAssociation, Background ofSpecialEducationand the Individuals with DisabilitiesEducationAct (IDEA); 2004."},{"key":"10.1016\/j.vaccine.2023.04.069_b0215","unstructured":"American Institutes for Research, Center forSpecialEducationFinance (CSEF); 2017."},{"key":"10.1016\/j.vaccine.2023.04.069_b0220","unstructured":"Centers for Disease Control and Prevention. CDC vaccine price list. 2020 March 15, 2021]; Available from: https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html."},{"key":"10.1016\/j.vaccine.2023.04.069_b0225","unstructured":"U.S Department of Veterans Affairs. National Acquisition Center. 2020 March 15, 2021]; Available from: https:\/\/www.vendorportal.ecms.va.gov\/NAC\/Pharma\/List."},{"key":"10.1016\/j.vaccine.2023.04.069_b0230","unstructured":"Centers for Medicare & Medicaid Services. Physician fee schedule. 2018 November 30, 2018]; Available from: https:\/\/www.cms.gov\/apps\/physician-fee-schedule\/search\/search-criteria.aspx."},{"issue":"7","key":"10.1016\/j.vaccine.2023.04.069_b0235","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.vaccine.2004.07.028","article-title":"Estimating medical practice expenses from administering adult influenza vaccinations","volume":"23","author":"Coleman","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.069_b0240","series-title":"Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation","first-page":"245","article-title":"Productivity Loss Tables","author":"Grosse","year":"2003"},{"key":"10.1016\/j.vaccine.2023.04.069_b0245","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0264-410X(99)00110-3","article-title":"Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults","volume":"17","author":"Nichol","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.069_b0250","series-title":"Morbidity and Mortality Weekly Report","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2018\u201319 influenza season","author":"Grohskopf","year":"2018"},{"key":"10.1016\/j.vaccine.2023.04.069_b0255","unstructured":"GDP Price Deflator. 2020 January 10, 2020]; Available from: https:\/\/www.bea.gov\/data\/prices-inflation\/gdp-price-deflator."},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ypmed.2012.02.015","article-title":"The vaccination coverage required to establish herd immunity against influenza viruses","volume":"55","author":"Plans-Rubi\u00f3","year":"2012","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jval.2010.10.026","article-title":"Valuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different ages","volume":"14","author":"Prosser","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2023.04.069_b0270","series-title":"Cost effectiveness in health and medicine","first-page":"496 pages","author":"Neumann","year":"2017"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.069_b0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/infdis\/jiaa080","article-title":"Relative effectiveness of influenza vaccines among the United States elderly, 2018\u20132019","volume":"222","author":"Izurieta","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.069_b0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.04.069_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.05.022","article-title":"A review of the cost-effectiveness of adult influenza vaccination and other preventive services","volume":"126","author":"Dabestani","year":"2019","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11597310-000000000-00000","article-title":"Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations","volume":"72","author":"Gatwood","year":"2012","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.069_b0295","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vaccine.2018.11.056","article-title":"Cost-effectiveness of adult vaccinations: A systematic review","volume":"37","author":"Leidner","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.04.069_b0300","doi-asserted-by":"crossref","first-page":"225","DOI":"10.7326\/0003-4819-137-4-200208200-00005","article-title":"Economic analysis of influenza vaccination and antiviral treatment for healthy working adults","volume":"137","author":"Lee","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0305","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjmed.2004.03.044","article-title":"Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis","volume":"118","author":"Rothberg","year":"2005","journal-title":"Am J Med"},{"issue":"27","key":"10.1016\/j.vaccine.2023.04.069_b0310","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.vaccine.2016.04.057","article-title":"Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women","volume":"34","author":"Xu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.069_b0315","unstructured":"Centers for Disease Control and Prevention. 2020-2021 Flu Season Summary. 2021 December 7, 2021]; Available from: https:\/\/www.cdc.gov\/flu\/season\/faq-flu-season-2020-2021.htm."},{"issue":"29","key":"10.1016\/j.vaccine.2023.04.069_b0320","doi-asserted-by":"crossref","first-page":"913","DOI":"10.15585\/mmwr.mm7129a1","article-title":"Influenza activity and composition of the 2022\u201323 influenza vaccine - United States, 2021\u201322 season","volume":"71","author":"Merced-Morales","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.04.069_b0325","series-title":"Morbidity and Mortality Weekly Report","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2016\u201317 influenza season","author":"Grohskopf","year":"2016"},{"key":"10.1016\/j.vaccine.2023.04.069_b0330","series-title":"Morbidity and Mortality Weekly Report","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2017\u201318 influenza season","author":"Grohskopf","year":"2017"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.069_b0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00019053-200523010-00005","article-title":"Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study","volume":"23","author":"Pisu","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"13","key":"10.1016\/j.vaccine.2023.04.069_b0340","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.vaccine.2009.01.108","article-title":"Influenza in older adults: impact of vaccination of school children","volume":"27","author":"Talbot","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:38Z","timestamp":1759404518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":68,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0264410X23004954"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of routine annual influenza vaccination by age and risk status","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}